| SNTI Stock | | | USD 3.68 0.17 4.84% |
This module uses fundamental data of Senti Biosciences to approximate its Piotroski F score. Senti Biosciences F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Senti Biosciences. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Senti Biosciences financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Senti Biosciences Altman Z Score,
Senti Biosciences Correlation,
Senti Biosciences Valuation, as well as analyze
Senti Biosciences Alpha and Beta and
Senti Biosciences Hype Analysis.
For more detail on how to invest in Senti Stock please use our
How to Invest in Senti Biosciences guide.
As of now, Senti Biosciences'
Debt Equity Ratio is increasing as compared to previous years. As of now, Senti Biosciences'
Capex To Revenue is decreasing as compared to previous years. The Senti Biosciences' current
Days Payables Outstanding is estimated to increase to 143.13, while
Price To Sales Ratio is projected to decrease to 12.49.
At this time, it appears that Senti Biosciences' Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Unavailable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Senti Biosciences Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Senti Biosciences is to make sure Senti is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Senti Biosciences' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Senti Biosciences' financial numbers are properly reported.
Senti Biosciences F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Senti Biosciences' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Senti Biosciences in a much-optimized way.
Click cells to compare fundamentals
About Senti Biosciences Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Senti Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Senti Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Senti Biosciences' managers, analysts, and investors.
About Senti Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Senti Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Senti Biosciences
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Senti Biosciences'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Senti Biosciences Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Senti Biosciences Stock: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Revenue Per Share | Quarterly Revenue Growth | Return On Assets | Return On Equity |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.